Peptide Drug: Design and Clinical Applications
ABSTRACT Peptide drugs possess superior biocompatibility and excellent specificity, making them a reliable choice in clinical treatment. They exert critical roles in disease‐associated metabolic reprogramming and immune modulation by activating cell signaling pathways, regulating metabolic processes...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | MedComm |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mco2.70287 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849331528544288768 |
|---|---|
| author | Yaqi Han YunKui Zhang Han Li Zhongliang Ma Yanmao Wang |
| author_facet | Yaqi Han YunKui Zhang Han Li Zhongliang Ma Yanmao Wang |
| author_sort | Yaqi Han |
| collection | DOAJ |
| description | ABSTRACT Peptide drugs possess superior biocompatibility and excellent specificity, making them a reliable choice in clinical treatment. They exert critical roles in disease‐associated metabolic reprogramming and immune modulation by activating cell signaling pathways, regulating metabolic processes, and immune cell functions. Notably, circular RNAs (circRNAs) have been shown to encode functional polypeptides. This finding offers new avenues for peptide drugs development. However, a summary of circRNA‐encoded polypeptides as peptide drug applications is relatively lacking. Therefore, we summarize the latest scientific advances in peptide drugs in the realm of diseases, with the focus on circRNA‐encoded polypeptides. We first delve into the functional mechanisms of peptide drugs within disease‐associated metabolic reprogramming and immune response. Subsequently, we provide an overview of the delivery and modification strategies of peptide drugs. Additionally, we summarize the encoding mechanisms of circRNAs and review the drug‐like applications of the polypeptides. We also highlight the potential challenges in the future development of circRNA‐based polypeptide drugs. In summary, we offer a systematic review of the research progress on circRNA‐encoded polypeptides, with the aim of providing novel perspective and ideas for the design and development of peptide drugs. |
| format | Article |
| id | doaj-art-27dbaccddba84b09b9968a6bb732cae8 |
| institution | Kabale University |
| issn | 2688-2663 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | MedComm |
| spelling | doaj-art-27dbaccddba84b09b9968a6bb732cae82025-08-20T03:46:33ZengWileyMedComm2688-26632025-08-0168n/an/a10.1002/mco2.70287Peptide Drug: Design and Clinical ApplicationsYaqi Han0YunKui Zhang1Han Li2Zhongliang Ma3Yanmao Wang4Lab for Noncoding RNA & Cancer School of Life Sciences Shanghai University Shanghai ChinaDepartment of Anesthesiology Fudan University Shanghai Cancer Center Shanghai ChinaLab for Noncoding RNA & Cancer School of Life Sciences Shanghai University Shanghai ChinaLab for Noncoding RNA & Cancer School of Life Sciences Shanghai University Shanghai ChinaShanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaABSTRACT Peptide drugs possess superior biocompatibility and excellent specificity, making them a reliable choice in clinical treatment. They exert critical roles in disease‐associated metabolic reprogramming and immune modulation by activating cell signaling pathways, regulating metabolic processes, and immune cell functions. Notably, circular RNAs (circRNAs) have been shown to encode functional polypeptides. This finding offers new avenues for peptide drugs development. However, a summary of circRNA‐encoded polypeptides as peptide drug applications is relatively lacking. Therefore, we summarize the latest scientific advances in peptide drugs in the realm of diseases, with the focus on circRNA‐encoded polypeptides. We first delve into the functional mechanisms of peptide drugs within disease‐associated metabolic reprogramming and immune response. Subsequently, we provide an overview of the delivery and modification strategies of peptide drugs. Additionally, we summarize the encoding mechanisms of circRNAs and review the drug‐like applications of the polypeptides. We also highlight the potential challenges in the future development of circRNA‐based polypeptide drugs. In summary, we offer a systematic review of the research progress on circRNA‐encoded polypeptides, with the aim of providing novel perspective and ideas for the design and development of peptide drugs.https://doi.org/10.1002/mco2.70287circRNA‐encoded polypeptidesdelivery strategyimmune performancemetabolic reprogrammingpeptide drug |
| spellingShingle | Yaqi Han YunKui Zhang Han Li Zhongliang Ma Yanmao Wang Peptide Drug: Design and Clinical Applications MedComm circRNA‐encoded polypeptides delivery strategy immune performance metabolic reprogramming peptide drug |
| title | Peptide Drug: Design and Clinical Applications |
| title_full | Peptide Drug: Design and Clinical Applications |
| title_fullStr | Peptide Drug: Design and Clinical Applications |
| title_full_unstemmed | Peptide Drug: Design and Clinical Applications |
| title_short | Peptide Drug: Design and Clinical Applications |
| title_sort | peptide drug design and clinical applications |
| topic | circRNA‐encoded polypeptides delivery strategy immune performance metabolic reprogramming peptide drug |
| url | https://doi.org/10.1002/mco2.70287 |
| work_keys_str_mv | AT yaqihan peptidedrugdesignandclinicalapplications AT yunkuizhang peptidedrugdesignandclinicalapplications AT hanli peptidedrugdesignandclinicalapplications AT zhongliangma peptidedrugdesignandclinicalapplications AT yanmaowang peptidedrugdesignandclinicalapplications |